• BREAK FREE FROM CANCER

    FANTOM aims to train 10 research fellows by participation in an internationally competitive research programme and address the clinical problems posed by Anaplastic Large Cell Lymphoma (ALCL) typified by aberrant ALK expression.

    READ MORE

FANTOM in Brief

The FANTOM Doctoral Network (DN) comprises of 7 beneficiaries and 12 associated partners in 5 EU countries, recruiting 10 researchers and will be embedded into an  established international research programme: The European Research Initiative on Anaplastic Lymphoma Kinase (ALK)-related malignancies (ERIA) and a clinical network: The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL).

The primary goal of the network is to train the recruited fellows by participation in this internationally competitive research programme and address the clinical problems posed by Anaplastic Large Cell Lymphoma (ALCL) typified by aberrant ALK expression.

The research and training activities will incorporate not only academic labs but also key research institutes, biotechnology companies, clinical trial bodies and Pharma to realise our research goals.

About FANTOM

A European funded project to train and nurture our future scientists through research in ALCL.

read more

Research projects

FANTOM Doctoral Network (DN) will recruit and train 10 fellows over 4 years to uncover the biology of ALCL.

read more

Outreach

We continuously strive for better communication and dissemination of our research findings.

read more

Contact

Find out more about the FANTOM Project or how you can get involved as fellow. Connect with us!

CONTACT US
7
RESEARCH PARTNERS
12
ASSOCIATED PARTNERS
10
RESEARCH STUDENTS
5
EUROPEAN COUNTRIES